- Petrochemicals
- Agrochemicals
- Flouro Chemicals
- API & Intermediates
- New Materials
- Pigments Intermediates
Address：
Room 801 Building E , Himalayas Centre, No.12 Mingchen Avenue. Nanjing, China
TEL：0086-25-52071213
Email：info@sinosannuo.com
APIs
ISO9001 Quality Management System , GMP & COS certificate are available. To learn more or to obtain specific information about products, please contact the Customer Service Center at 0086-25-52461229 or use the Contact us link below. Email: sales@sinosannuo.com
|
Therapeutic area |
API name |
Indication |
CAS NO |
|
Blood disease |
Lanthanum Carbonate |
Hyperphosphatemia |
6487-39-4 |
|
Tolvaptan |
Hyponatremia |
150683-30-0 |
|
|
Idarubicin Hydrochloride |
Leukemia |
57852-57-0 |
|
|
Anti-neoplastic |
Aprepitant |
Nausea and vomiting during antitumor chemotherapy |
170729-80-3 |
|
Lenvatinib Mesilate |
Liver cancer; Thyroid cancer |
857890-39-2 |
|
|
Raltitrexed |
Colorectal cancer |
112887-68-0 |
|
|
Regorafenib |
Colorectal cancer |
1019206-88-2 |
|
|
Pazopanib Hydrochloride |
Renal cell carcinoma; Soft tissue sarcoma |
635702-64-6 |
|
|
Bortezomib |
Mantle cell lymphoma |
179324-69-7 |
|
|
Anticoagulation |
Apixaban |
Anticoagulants. Venous thrombosis. |
503612-47-3 |
|
Clopidogrel Bisulfate |
Inhibit platelet aggregation, stroke, and myocardial infarction.； |
135046-48-9 |
|
|
Ticagrelor |
Inhibit platelet aggregation and acute coronary syndrome |
274693-27-5 |
|
|
Rivaroxaban |
Anticoagulants. Thrombus |
366789-02-8 |
|
|
Hepatopathy |
Sofosbuvir |
Hepatitis C Virus |
503612-47-3 |
|
Avatrombopag Maleate
|
Chronic liver disease. Thrombopenia |
677007-74-8 |
|
Therapeutic area |
API name |
Indication |
CAS NO |
|
Digestion |
Lubiprostone |
Anti-constipation |
333963-40-9 |
|
Cardiac-cerebral and Geriatric disease |
Olmesartan Medoxmil |
Hypertension |
144689-63-4 |
|
Sitagliptin Phosphate |
Type 2 diabetes. Chronic kidney disease |
654671-77-9 |
|
|
Dapagliflozin |
Type 2 diabetes. Heart failure |
461432-26-8 |
|
|
Macitentan |
Pulmonary arterial hypertension |
556797-16-1 |
|
|
Mirabegron |
Urgent urination, frequent urination and incontinence caused by overactive bladder |
223673-61-8 |
|
|
Tadalafil |
Erectile dysfunction |
171596-29-5 |
|
|
Tofacitinib Citrate |
Rheumatoid arthritis |
540737-29-9 |
|
|
Anaesthetic |
Parecoxib Sodium |
Analgesia |
198470-85-8 |
|
|
Dexmedetomidine Hydrochloride |
Sedation |
145108-58-3 |
The products listed above are only for scientific research and experiments, not for any commercial purposes. If the above products involve the patent protection, we are committed no manufacture and sale of above products before the expiry of the patent.